IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

Journal of Clinical Investigation

Volumn 118, Issue 2, 2008, Pages 534-544

  Sugimoto, Ken ^a,b   Ogawa, Atsuhiro ^a,b,c   Mizoguchi, Emiko ^a,b   Shimomura, Yasuyo ^a,b   Andoh, Akira ^c   Bhan, Atul K ^a,b   Blumberg, Richard S ^b,d,e   Xavier, Ramnik J ^a,b   Mizoguchi, Atsushi ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG TARGETING; ENTERITIS; GENE DELIVERY SYSTEM; GOBLET CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH2 CELL; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GOBLET CELLS; HUMANS; INTERLEUKINS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUCUS; STAT3 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 38849141814     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33194     Document Type: Article

References (52)

1. Dumoutier, L., Louahed, J., and Renauld, J.C. 2000. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:1814-1819.
2. Fickenscher, H., et al. 2002. The interleukin-10 family of cytokines. Trends Immunol. 23:89-96.
3. Pestka, S., et al. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929-979.
4. Liang, S.C., et al. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
5. Zheng, Y., et al. 2007. Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445:648-651.
6. Radaeva, S., Sun, R., Pan, H.N., Hong, F., and Gao, B. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology. 39:1332-1342.
7. Wolk, K., et al. 2004. IL-22 increases the innate immunity of tissues. Immunity. 21:241-254.
8. Brand, S., et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G827-G838.
9. Nagalakshmi, M.L., Rascle, A., Zurawski, S., Menon, S., and de Waal Malefyt, R. 2004. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4:679-691.
10. Wolk, K., et al. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-1323.
11. Andoh, A., et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 129:969-984.
12. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-429.
13. Shirazi, T., Longman, R.J., Corfield, A.P., and Probert, C.S.J. 2000. Mucins and inflammatory bowel disease. Postgrad. Med. J. 76:473-478.
14. Targan, S.R., and Karp, L.C. 2005. Defects in mucosal immunity leading to ulcerative colitis. Immunol. Rev. 206:296-305.
15. Yen, D., et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-1316.
16. Strober, W., Fuss, I., and Mannon, P. 2007. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117:514-521.
17. Wolk, K., et al. 2007. IL-22 induces IL-22 Induces lipopolysaccharide- binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 178:5973-5981.
18. Bhan, A.K., Mizoguchi, E., Smith, R.N., and Mizoguchi, A. 1999. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 169:195-207.
19. Mombaerts, P., et al. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:274-282.
20. Powrie, F. 2004. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann. N. Y. Acad. Sci. 1029:132-141.
21. Mizoguchi, E., et al. 2003. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology. 125:148-161.
22. Steidler, L., et al. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 289:1352-1355.
23. Wirtz, S., Becker, C., Blumberg, R., Galle, P.R., and Neurath, M.F. 2002. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 168:411-420.
24. Wiethoff, C.M., Smith, J.G., Koe, G.S., and Middaugh, C.R. 2001. The potential role of proteoglycans in cationic lipid-mediated gene delivery. J. Biol. Chem. 276:32806-32813.
25. Sioud, M., and Sorensen, D.R. 2003. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312:1220-1225.
26. Cryan, S.A., and O'Driscoll, C.M. 2003. Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop. Pharm. Res. 20:569-575.
27. McAlindon, M.E., et al. 1999. Investigation of the expression of IL-1? converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages. Clin. Exp. Immunol. 116:251-257.
28. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R.S., and Bhan, A.K. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 16:219-230.
29. Jacobs, L.R., and Huber, P.W. 1985. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J. Clin. Invest. 75:112-118.
30. McCormick, D.A., Horton, L.W., and Mee, A.S. 1990. Mucin depletion in inflammatory bowel disease. J. Clin. Pathol. 43:143-146.
31. Yuan, Z.L., et al. 2004. Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol. Cell. Biol. 24:9390-9400.
32. Chen, Y., et al. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278:17036-17043.
33. van der Sluis, M., et al. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that muc2 is critical for colonic protection. Gastroenterology. 131:117-129.
34. Ho, S.B., et al. 2006. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing.Gastroenterology. 131:1501-1517.
35. Seril, D.N., Liao, J., Ho, K.L., Yang, C.S., and Yang, G.Y. 2002. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-accetylcysteine. Carcinogenesis. 23:993-1001.
36. Logsdon, N.J., et al. 2004. The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation. J. Mol. Biol. 342:503-514.
37. + T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity. 20:681-693.
38. Xu, W., et al. 2001. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acad. Sci. U. S. A. 98:9511-9516.
39. Atreya, R., et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat. Med. 6:583-588.
40. Takeda, K., et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:39-47.
41. Tebbutt, N.C., et al. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8:1089-1097.
42. Welte, T., et al. 2003. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. U. S. A. 100:1879-1884.
43. Corfield, A.P., Carroll, D., Myerscough, N., and Probert, C.S. 2001. Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6:D1321-D1357.
44. An, G., et al. 2007. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 204:1417-1429.
45. Mashimo, H., Wu, D.C., Podolsky, D.K., and Fishman, M.C. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:262-265.
46. McVay, L.D., et al. 2006. Absence of bacterially induced RELM? reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116:2914-2923.
47. Uhlig, H.H., et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 25:309-318.
48. Kullberg, M.C., et al. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485-2494.
49. Duerr, R.H., et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 314:1461-1463.
50. Schnyder-Candrian, S., et al. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203:2715-2725.
51. Matsuo, K., Ota, H., Akamatsu, T., Sugiyama, A., and Katsuyama, T. 1997. Histochemistry of the surface mucous gel layer of the human colon. Gut. 40:782-789.
52. Mizoguchi, A., Mizoguchi, E., and Bhan, A.K. 1999. The critical role of interleukin-4 but not interferon-γ in the pathogenesis of colitis in T cell receptor α mutant mice. Gastroenterology. 116:320-326.